Immunomodulator FTY720 Induces eNOS-Dependent Arterial Vasodilatation via the Lysophospholipid Receptor S1P <sub>3</sub>
Markus Tölle(Charité - Universitätsmedizin Berlin), Markus van der Giet(Charité - Universitätsmedizin Berlin), Michael Schäfers(Blackberry (United States)), Vera Jankowski(Scripps Research Institute), Gilbert Schönfelder(Charité - Universitätsmedizin Berlin), Petra Keul(Scripps Research Institute), Walter Zidek(Charité - Universitätsmedizin Berlin), Volker Brinkmann(Max Planck Institute for Infection Biology), Bodo Levkau(Düsseldorf University Hospital), Günter Giebing(Scripps Research Institute), Jerold Chun(Sanford Burnham Prebys Medical Discovery Institute), Joachim Jankowski(Charité - Universitätsmedizin Berlin), Karin von Wnuck Lipinski(Heinrich Heine University Düsseldorf)
Cited by 123
Related Papers
Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain
|Nature Biotechnology|2017|1.1k
Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain
|Science|2016|1.1k
LPA Receptors: Subtypes and Biological Actions
|The Annual Review of Pharmacology and Toxicology|2010|851
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
|Nature Medicine|2007|820
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
|Clinical Neuropharmacology|2010|794